Skip to main content
TEVA $36.77 +0.68%
TEVA logo

TEVA · Teva Pharmaceutical Industries Ltd

Track TEVA — free
$36.77 +0.25 (+0.68%) At close · Aug 14
Market Cap
$42.85B
Shares
1.17B
All earnings calls

Earnings call · FY2023 Q2

Teva Pharmaceutical Industries Ltd Q2 FY2023 Earnings Call

Teva Pharmaceutical Industries Ltd Q2 FY2023 Earnings Call

Concluded Aug 2, 2023
Aug 2, 2023 0 turns
Period
FY2023 Q2
Runtime
Sources
2 artifacts

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.

Research coverage

2 live sources

Switch sources without leaving this page or losing your listening position.

Revenue $3.88B +2.4% YoY
Diluted EPS -$0.78
Gross margin 46.3% -1.1 pp YoY
Net income -$872.00M

Research materials

Open the source you need; every reader stays inside this workspace.

Quarter detail

How the reported period landed and where the business moved.

Revenue · segments

United States Segment$1.89B
Europe Segment$1.16B -0.7% YoY
International Markets$578.00M +27.3% YoY
Other Activities$245.00M -4.7% YoY
Full-screen source Call document